1.Coronary Slow Flow Phenomenon Leads to ST Elevation Myocardial Infarction.
Korean Circulation Journal 2013;43(3):196-198
The exact etiology of the coronary slow flow phenomenon (CSFP) is not certain. CSFP is not a normal variant as it is an absolutely pathological entity. Furthermore, CSFP not only leads to myocardial ischemia but it can also cause classical acute ST elevation myocardial infarction, which necessitates coronary angiography for a definite diagnosis.
Anterior Wall Myocardial Infarction
;
Coronary Angiography
;
Myocardial Infarction
;
Myocardial Ischemia
;
No-Reflow Phenomenon
2.The Role of Distal Protection Devices for Cardiovascular Intervention.
Seung Hwan HAN ; Woong Chol KANG ; Tae Hoon AHN ; Eak Kyun SHIN
Korean Circulation Journal 2003;33(9):746-753
Distal embolization, such as plaque debris and thrombus during percutaneous coronary and carotid interventions, often lead to virtually untreatable small vessel occlusions and the no-reflow phenomenon, which may cause periprocedural end organ ischemia and infarction. This is clinically important as the one-year mortality is doubled in patients with a periprocedural myocardial infarction. To prevent a distal embolization a number of distal protection devices have been developed, with others still under development, such as a balloon occlusion device (PercuSurge GuardWire), numerous filter devices (FilterWire EX, AngioGuard, Mednova Neuroshield, AccuNet) and a catheter occlusion device (Parodi Anti-Emboli System). The usefulness and roles of distal protection devices, for cardiovascular intervention, are reviewed.
Angioplasty, Balloon
;
Balloon Occlusion
;
Catheters
;
Humans
;
Infarction
;
Ischemia
;
Mortality
;
Myocardial Infarction
;
No-Reflow Phenomenon
;
Thrombosis
3.Coronary Flow Doppler Profile in No-Reflex Phenomenon after Direct PTCA in Acute Myocardial Infarction.
Han Soo KIM ; Yun Kyung CHO ; Won KIM ; Suk Kyun SHIN ; Joon Han SHIN ; Seung Jea TAHK ; Byung Il CHOI
Korean Circulation Journal 1996;26(1):124-129
Profound reduction of anterograde coronary flow with concomitant ischemia is seen occasionally during percutaneous coronary intervention despite technically successful procedure. We found interesting coronary flow pattern in a patient with acute myocardial infarction, showing angiographic no reflow phenomenon after direct PTCA. The coronary blood flow pattern of the angiographic no-reflow phenomenon in this case was characterized by minimal systolic flow and sharp deceleration of diastolic flow. Coronary flow reserve calculated by the ratio of adenosine induced maximal hyperemic velocity and basal velocity was reduced. The Dopplertipped guide wire was useful for observation of phasic coronary flow pattern of angiographic no-reflow phenomenon.
Adenosine
;
Deceleration
;
Humans
;
Ischemia
;
Myocardial Infarction*
;
No-Reflow Phenomenon
;
Percutaneous Coronary Intervention
4.Acute Intestinal Ischemia Following Aortic Reconstruction.
Journal of the Korean Society for Vascular Surgery 2002;18(2):312-315
No abstract available.
Ischemia*
5.Treatment of Acute Mesenteric Ischemia.
Journal of the Korean Society for Vascular Surgery 2002;18(2):296-298
No abstract available.
Ischemia*
6.A case of chronic mesenterric ischemia
Duck Jong HAN ; Suk Koo KIM ; Kun Choon PARK ; Young Il MIN
Journal of the Korean Society for Vascular Surgery 1991;7(1):42-47
No abstract available.
Ischemia
7.No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
Chonnam Medical Journal 2016;52(1):38-44
Recently, percutaneous coronary intervention has been the treatment of choice in most acute myocardial infarction cases. Although the results of percutaneous coronary interventions have ben good, the no-reflow phenomenon and distal embolization of intracoronary thrombus are still major problems even after successful interventions. In this article, we will briefly review the deleterious effects of no-reflow and distal embolization of intracoronary thrombus during percutaneous coronary interventions. The current trials focused on the prevention and treatment of the no-reflow phenomenon and intracoronary thrombus.
Myocardial Infarction
;
No-Reflow Phenomenon
;
Percutaneous Coronary Intervention
;
Thrombosis
8.Biochemical Alterations of Jungular Venous Blood after the Complete Cerebral Ishemia: Lactate and Latate/Pyruvate Ratios of Canine Jugular Venous Blood following Complete Cerebral Bloody-ischemia.
Joo Myung KIM ; Soon Guan CHOI ; Duck Young CHOI ; Kwang Seh RHIM
Journal of Korean Neurosurgical Society 1977;6(2):311-320
If in the aneurysmal rupture patients the brain metabolic parameters obtained from blood chemistry were significant and useful in clinical practice, it cannot be overstimated. Hansdorfer er al.(1973) reported that lactate, pyruvate, uric acid and alpha-HBDH of central venous blood obtained form the patients with brain contusion in basal metabolic state were significantly increased and they were useful in evaluating the prognosis of the patients. Zooping(1970) and Broderson(1974) also had tried to evaluate the prognosis and brain metabolic status of the comatous patients with blood gas analysis and CSF biochemistry. They encouraged us to estimate lactate and lactate/pyruvate ratios of canine jugular venous blood combined with gas analysis. Complete cerebral bloody-ischemia similar with initial stage of aneurysmal rupture was induced by the instanteneous elevation of intracranial pressure 30 mmHg above systemic arterial pressure by infusion of blood and mock CSF mixture into the cisterna arrest or pulmonary hypertension were discarded. At the end of the 5 minutes ischemic period, the needle tip which was inserted in to cisterna magna was removed without decreasing intracranial pressure. At 3 hours, 24 hours, 48 hours and 72 hours after ischemic period jugular venous and arterial blood were sampled for determination of lactate and pyruvate, and blood gas analysis. The following results were obtained. ie ; 1. Both lactate and pyruvate of canine jugular venous blood were increased from 3 hours and reached peak level at 24 hours after insult. Standard value of lactate and pyruvate were 1.416mM and 0.075mM and peak values were 2.429 and 0.165mM(P<0.05). 2. The more severe the neurological deficits of the animals, the highest levels of lactate and pyruvate were observed. 3. The lactate concentrations in 48 hours and 72 hours sample slopped down from 24 hours peak level but were significantly higher than those of standard. 4. Pyruvate returned to the normal range within 48 hours after insult. 5. L/P ratios were not changed significantly until 48 hours after insult but steeply elevated in 72 hours sample. 6. In gas analysis all the animals show respiratory alkalosis after insult. 7. In arterial boundary zones multiple focal ischemia were found in necropsy which was thought as reflecting no-reflow phenomenon. We concluded that elevation of lactate and pyruvate in early stage must be due to the hyperventilation after insult and lactate of late stage reflected CSF lactic acidosis.
Acidosis, Lactic
;
Alkalosis, Respiratory
;
Aneurysm
;
Animals
;
Arterial Pressure
;
Biochemistry
;
Blood Gas Analysis
;
Brain
;
Brain Injuries
;
Chemistry
;
Cisterna Magna
;
Humans
;
Hypertension, Pulmonary
;
Hyperventilation
;
Intracranial Pressure
;
Ischemia
;
Lactic Acid*
;
Needles
;
No-Reflow Phenomenon
;
Prognosis
;
Pyruvic Acid
;
Reference Values
;
Rupture
;
Uric Acid
9.Effect of Pentoxifylline on the Cerebral No-reflow Phenomenon after Cardiac Arrest in Rat.
Kyoung Ho CHOI ; Dong Rul OH ; Won Jae LEE ; Hyung Kook KIM ; Se Kyung KIM ; Tae Hwan CHOI ; Jang Seong CHAE
Journal of the Korean Society of Emergency Medicine 2000;11(1):1-10
BACKGROUND: Successful resuscitation of the brain requires unimpaired blood recirculation. However, unfortunately there are several factors against the successful recirculation. No-reflow phenomenon, characterized by a lack of reperfusion after cerebral ischemia, is the most important pathogenic factor during the early period of spontaneous circulation(ROSC). This study addresses question that pentoxifylline(PTX) ameliorates no-reflow phenomenon after cardiac arrest. METHODS: Fourteen rats were divided three group ; Sham group(n=2), 12 minutes cardiac arrest group without PTX(group I, n=6), and 12 minutes cardiac arrest group pretreated with PTX(group II, n=6). Group II were premedicated by intravascular injection of 5mg/kg PTX into the external jugular vein before 5minutes of the arrest-induction. We induced cardiac arrest with endotracheal clamping and muscle relaxant. And then, resuscitation was initiated. Arterial blood samples were drawn at the femoral artery before 5 minutes of arrest-induction and at the 5 minutes after restoration of ROSC. Reperfusion of brain was visualized by injection of 0.3g/kg of 15% FITC-albumin at 5 minutes after restoration of ROSC, and the animals were decapitated 2 minutes later. The left hemisphere was fixed with 4% formalin, and coronal sections of 200um thickness at three different standard levels of the rat brain were investigated with fluorescence microscopy. Density of microvasular filling were identified and calculated. RESULTS: Our observation demonstrated that 1. There were no significant differences of blood pressures, heart rates, and results of blood gas analysis between group I and II during the prearrest steady state. 2. There were no significant differences of blood pressures, heart rates, and results of blood gas analysis between group Iand II at 5minutes after ROSC. 3. Group II premedicated with PTX, showed significant increased capillary refiling(0.310+/-0.035)than group I without PTX(0.181+/-0.040). CONCLUSIONS : The results showed that during the prearrest steady state, premedication of PTX ameliorated the no-reflow phenomenon in the rat model of the asphyxial arrest. Further experimental studies are required to focus on the effects of postarrest infused PTX, The neurologic outcome, and the clinical applications.
Animals
;
Blood Gas Analysis
;
Brain
;
Brain Ischemia
;
Capillaries
;
Constriction
;
Femoral Artery
;
Formaldehyde
;
Heart Arrest*
;
Heart Arrest, Induced
;
Heart Rate
;
Jugular Veins
;
Microscopy, Fluorescence
;
Models, Animal
;
No-Reflow Phenomenon*
;
Pentoxifylline*
;
Premedication
;
Rats*
;
Reperfusion
;
Resuscitation
10.Effect of Coronary Angioplasty on QT Dispersion.
Yi Chul SYNN ; Yoon Nyun KIM ; Dae Woo HYUN ; Seong Ho HUR ; Nam Hee PARK
Korean Circulation Journal 2003;33(11):977-986
BACKGROUND AND OBJECTIVES: The change in QT dispersion (QTd) immediately after balloon angioplasty reflects the immediate impact of ischemia. We intended to analyze the immediate impact of ischemia on myocardial repolarization. MATERIALS AND METHODS: Forty-six patients who underwent percutaneous coronary intervention were enrolled. The standard 12-lead electrocardiogram (ECG) was recorded just before, during, and 1 minute, 5 minutes and 10 minutes after ballooning. QTd was determined by the difference between the maximum and minimum QT interval (QTi). We then calculated the corrected QTi (QTc) using Bazett's formula. QTd and QTi were compared according to the site of the ballooned vessel, number of ballooned vessels and history of acute myocardial infarction. RESULTS: QTd just before, during, and 1 minute, 5 minutes and 10 minutes after ballooning were 35.21+/-10.36 msec, 54.56+/-16.89 msec, 50.91+/-14.20 msec, 45.52+/-9.6 msec and 38.56+/-10.89 msec, respectively. QTd increased markedly during ballooning, but after myocardial ischemia was relieved, decreased rapidly. Ten minutes after ballooning, QTd was reduced to a similar level as that of baseline. There were no significant differences between the AMI and non-myocardial infarction groups, single-vessel and multi-vessel groups, and the location of the stenosed artery. There was no significant difference in QTi according to different stenosed vessel. CONCLUSION: QT (QTc) dispersion increased rapidly with myocardial ischemia and reduced rapidly after the myocardial ischemia was resolved. Therefore, increased QTd can be used as an early clue of myocardial ischemia.
Angioplasty*
;
Angioplasty, Balloon
;
Arteries
;
Electrocardiography
;
Humans
;
Infarction
;
Ischemia
;
Myocardial Infarction
;
Myocardial Ischemia
;
Percutaneous Coronary Intervention